abstract "tranilast compositions and co-crystals" new tranilast complexes and new tranilast co-crystals are described. these include a 1: 1 tranilast nicotinamide complex, 1: 1 tranilast nicotinamide co-crystal, tranilast saccharin complex, 1: 1, tranilast saccharin co-crystal, 1: 1, a gentisic acid complex 1: 1 tranilast, 1: 1 tranilast gentisic acid co - crystal, 1: 1 tranilast salicylic acid complex, 1: 1 tranilast salicylic acid co - crystal, 1 tranilast urea complex 1 : 1, tranilast urea co - crystal 1: 1, a tranilast 4 - aminobenzoic acid complex 1: 1, tranilast 4 - aminobenzoic acid co - crystal, a 2,4 - dihydrobenzoic acid complex of 1: 1 tranilast and a 1: 1 tranylast 2,4-dihydrobenzoic acid co-crystal are also disclosed pharmaceutical compositions containing a tranilast or co-crystal complex of the invention and a pharmaceutically acceptable carrier. methods of treatment using tranilast complexes and co-crystals, as well as the pharmaceutical compositions which are described.resumo "composições de tranilast e co-cristais" novos complexos de tranilast e novos co-cristais de tranilast são descritos. estes incluem um complexo de nicotinamida de tranilast 1 : 1, co – cristal de nicotinamida de tranilast 1 : 1, complexo de sacarina de tranilast, 1 : 1, co – cristal de sacarina de tranilast, 1 : 1, um complexo de ácido gentisico de tranilast 1 : 1, um co – cristal de ácido gentisico de tranilast 1 : 1, um complexo de ácido salicílico de tranilast 1: 1, um co – cristal de ácido salicílico de tranilast 1: 1, um complexo de ureia de tranilast 1 : 1, co – cristal de ureia de tranilast 1 : 1, um complexo de ácido 4 - aminobenzóico de tranilast 1: 1, co – cristal de ácido 4 - aminobenzóico de tranilast 1: 1, um complexo de ácido 2,4-dihidrobenzóico de tranilast 1: 1 e um co – cristal de ácido 2,4-dihidrobenzóico de tranilast 1: 1. também são divulgadas composições farmacêuticas contendo um complexo de tranilast ou co-cristal do invento e um veículo farmaceuticamente a
